Drug Therapy Combination
Mostrando 1-12 de 314 artigos, teses e dissertações.
-
1. Deve-se retirar a sulfonilureia quando for iniciada a insulina em pacientes com diabetes tipo 2 usando metformina e sulfonilureia em doses máximas e sem controle glicêmico adequado?
Não é necessário retirar a sulfonilureia ao iniciar insulina NPH em pacientes com diabetes tipo 2. A manutenção do uso da sulfonilureia durante o início do tratamento com insulina NPH (insulina basal) está associada ao uso de doses 30% menores de insulina, menor risco de hipoglicemias e menor ganho de peso.
Deve-se suspender a sulfonilureia e
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Vestibular Syndromes in Childhood and Adolescence
Abstract Introduction The prevalence of vestibular disorders in childhood ranges from 0.4% to 15%; they may be the result of several factors, but most of the time it's an episodic vestibular syndrome related to migraine equivalents. Objective To evaluate the diagnostic and therapeutic aspects of children with vestibular signs and symptoms. Methods The pre
Int. Arch. Otorhinolaryngol.. Publicado em: 2020-12
-
3. Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
ABSTRACT Background: The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival. Studies comparing different induction chemotherapy regimens have shown that triple combinations have better results than double combinations. However, comparisons among d
Hematol., Transfus. Cell Ther.. Publicado em: 2020-06
-
4. Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria
Abstract Artemisinin-based combination therapy (ACT) is recommended by the World Health Organization for the treatment of uncomplicated malaria. Currently, there appears to be a downward trend in the efficacy of ACT in some parts of sub-Saharan Africa because some patients have been positive for Plasmodium parasite 3 days after artemether-lumefantrine treatm
Rev. Soc. Bras. Med. Trop.. Publicado em: 10/10/2019
-
5. Benzbromarone in the treatment of gout
Abstract Background Benzbromarone is a uricosuric drug that has been used in the treatment of gout over the last 30 years. Due to its potent inhibition of the dominant apical (luminal) urate exchanger in the human proximal tubule URAT1, it reduces the urate reabsorption, diminishing serum urate levels and therefore preventing gout flares. Main body of the
Adv. rheumatol.. Publicado em: 15/08/2019
-
6. Efeitos dos probióticos no perfil lipídico: revisão sistemática
Resumo As alterações na microbiota intestinal podem modular mecanismos envolvendo fatores de risco para doenças cardiovasculares, incluindo as dislipidemias. O objetivo foi revisar os efeitos da suplementação de probióticos na prevenção e no tratamento de alterações do perfil lipídico. As pesquisas foram feitas na base de dados PubMed, com os desc
J. vasc. bras.. Publicado em: 15/08/2019
-
7. 2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis
Abstract The objective of this document is to provide a comprehensive update of the recommendations of Brazilian Society of Rheumatology on drug treatment of rheumatoid arthritis (RA), based on a systematic literature review and on the opinion of a panel of rheumatologists. Four general principles and eleven recommendations were approved. General principles:
Adv. rheumatol.. Publicado em: 29/07/2019
-
8. Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
ABSTRACT Polymyxin B is one of the last resort option for carbapenem-resistant Klebsiella pneumoniae (CRKP) bloodstream infection in China. Therefore, the timing of administration of polymyxin is frequently delayed. We collected 40 cases of CRKP bloodstream infections (BSIs) treated with combinations based on polymyxin B over 30 months. The primary outcome,
Braz J Infect Dis. Publicado em: 20/05/2019
-
9. Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review
RESUMO Os inibidores do cotransportador de sódio-glicose do tipo 2 (SGLT2i) são medicamentos que atuam mantendo a glicosúria. Estudos recentes têm demonstrado efeitos promissores desses no tratamento de diabetes mellitus tipo 2 (DM2). No entanto, pode haver um risco aumentado de desenvolver infecções do trato urinário (UTI) em pacientes tratados com e
Rev. Assoc. Med. Bras.. Publicado em: 2019-02
-
10. A case series pilot study on the combination of 5-aminolevulinic acid and photodynamic therapy (ALA-PDT) for treatment of vitiligo
Abstract: Background: To study the effective therapeutic concentration, drug application duration, irradiation duration and irradiation dosage of 5-aminolevulinic acid photodynamic therapy (ALA-PDT) for treating vitiligo and observe its clinical efficacy. Objective: To assess the clinical efficacy of ALA-PDT for treating vitiligo. Methods: ALA with differ
An. Bras. Dermatol.. Publicado em: 2018-08
-
11. Perspectives of Dendrimer-based Nanoparticles in Cancer Therapy
Abstract Currently, cancer is the second most common cause of death in the United States, exceeded only by heart disease. Chemotherapy traditionally suffers from a non-specific distribution, with only a small fraction of the drug reaching the tumor, in this sense, the use of dendrimers incorporating drugs non-covalently encapsulated inside the dendrimer or c
An. Acad. Bras. Ciênc.. Publicado em: 26/07/2018
-
12. In Vitro additive effect on griseofulvin and terbinafine combinations against multidrug-resistant dermatophytes
ABSTRACT Griseofulvin (GF) and terbinafine (TF) are commonly used drugs to treat dermatophytosis, a fungal infection of the skin. Today there is an increase in drug resistance to these antifungals which highlight the need for alternative synergistic therapies. Minimum Inhibitory Concentration (MIC) of GF and TF were determined against fungi clinical isolates
Braz. J. Pharm. Sci.. Publicado em: 26/07/2018